| Literature DB >> 35770098 |
Shaoyang Liu1, Ruiyuan Zhang1, Xing Zhang1, Shun Zhu1, Siyu Liu1, Jue Yang1, Zhiping Li2, Tianhui Gao1, Fang Liu1, Huiling Hu1.
Abstract
Polygoni Cuspidati Rhizoma et Radix, the dry roots and stems of Reynoutria japonica Houtt (called Huzhang, HZ in Chinese), is a traditional and popular chinese medicinal herb for thousands of years. As a widely used ethnomedicine in Asia including China, Japan, and Korea, HZ can invigorate the blood, cool heat, and resolve toxicity, which is commonly used in the treatment of favus, jaundice, scald, and constipation. However, HZ is now considered an invasive plant in the United States and many European countries. Therefore, in order to take advantage of HZ and solve the problem of biological invasion, scholars around the world have carried out abundant research studies on HZ. Until now, about 110 compounds have been isolated and identified from HZ, in which anthraquinones, stilbenes, and flavonoids would be the main bioactive ingredients for its pharmacological properties, such as microcirculation improvement, myocardial protective effects, endocrine regulation, anti-atherosclerotic activity, anti-oxidant activity, anti-tumor activity, anti-viral activity, and treatment of skin inflammation, burns, and scalds. HZ has a variety of active ingredients and broad pharmacological activities. It is widely used in health products, cosmetics, and even animal husbandry feed and has no obvious toxicity. Efforts should be made to develop more products such as effective drugs, health care products, cosmetics, and agricultural and animal husbandry products to benefit mankind.Entities:
Keywords: Reynoutria japonica Houtt.; botany and ethnopharmacology; pharmacological activity; phytochemistry; quality control
Year: 2022 PMID: 35770098 PMCID: PMC9234309 DOI: 10.3389/fphar.2022.863707
Source DB: PubMed Journal: Front Pharmacol ISSN: 1663-9812 Impact factor: 5.988